Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

December 1, 2024

Conditions

Poly Cystic Ovary Syndrome

Interventions

DRUG

Daflon

Daflon; two film coated tablets 500 mg daily

DRUG

Combined oral contraceptive

Yassmin ® film-coated tablets 3 mg of drospirenone and 0.03 mg of ethinyl estradiol once daily daily

DRUG

Metformin

Glucophage ® 500 tablets twice daily

All Listed Sponsors

lead

Ain Shams University

OTHER